Drug intelligence / Profile preview

Xishu capsule

Development stage: Preclinical
Lead developer: Kaken Pharmaceutical
Administration: Oral

Overview

Xishu capsule (膝舒胶囊) is a drug currently under clinical investigation for the treatment of knee osteoarthritis. It is administered orally as a capsule. The specific ingredients, mechanism of action, and manufacturer of Xishu capsule are not publicly available. It is being studied in clinical trials, with one such study combining it with Fu's Subcutaneous Needling or Electroacupuncture for knee osteoarthritis.

Other names: 膝舒胶囊

Beyond the preview

Go deeper on Xishu capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xishu capsule.

Explore the full profile